Lensar (Nasdaq:LNSR) announced today that it received FDA 510(k) clearance for its next-generation Ally system. Orlando, Florida–based Lensar designed the Ally adaptive cataract treatment system to enable cataract surgeons to complete the femtosecond-laser-assisted cataract (FLACS) procedure seamlessly in a single, sterile environment. According to a news release, the company intends to deliver the first Ally […]
Optical/Ophthalmic
Ocular Therapeutix adds two executives to leadership team
Ocular Therapeutix (Nasdaq:OCUL) announced today that it made two additions to its executive leadership team. Bedford, Massachusetts-based Ocular Therapeutix appointed a chief medical advisor (CMA) — a newly created role — as well as a new chief medical officer (CMO). Additionally, the company created a new role called chief strategy advisor (CSA) for its departing […]
CooperVision buys EnsEyes to accelerate specialty contact lens growth in Nordic countries
CooperVision announced today that it acquired EnsEyes, a supplier of orthokeratology and scleral contact lenses. The San Ramon, California-based company said the acquisition of EnsEyes will help accelerate the growth of specialty lens adoption across the Nordic markets. EnsEyes, with headquarters in Kolding, Denmark, has partners in Denmark as well as Sweden, Norway and Finland, […]
Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment
Alcon (NYSE:ACL) announced today that it agreed to acquire Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals. Geneva, Switzerland-based Alcon will pay $60 million upfront to Kala for the dry eye treatment. As part of the agreement, the company will also acquire Kala’s Inveltys corticosteroid for twice-per-day treatment of post-operative inflammation and pain following ocular surgery. Get the […]
Ocular Therapeutix posts mixed-bag Q1 results
Ocular Therapeutix (NSDQ:OCUL) this week posted first-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates. The Bedford, Massachusetts-based company reported losses of $12.5 million, or -16¢ per share, on sales of $13.2 million for the three months ended March 31, for sales growth of 79.6% compared with Q1 2021. Earnings […]
Glaukos posts Street-beating Q1 results
Glaukos (NYSE:GKOS) this week posted first-quarter results that beat the overall consensus on Wall Street. The San Clemente, California-based company reported profits of $5.4 million, or 11¢ per share, on sales of $67.7 million for the three months ended March 31, for a sales loss of -0.42% compared with Q1 2021. Adjusted to exclude one-time items, […]
Staar Surgical rises on Street-beating Q1, Evo lens shipments remain ‘robust’
Staar Surgical (Nasdaq:STAA) shares got a boost this morning on first-quarter results that topped the consensus forecast. STAA shares were up 11% at $70.91 per share as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 0.4%. However, Staar shares were down […]
Johnson & Johnson Vision wins Fast Company award for drug-eluting contact lens
Johnson & Johnson Vision announced today that it was named a winner of Fast Company’s 2022 World Changing Ideas Awards. The eye health business arm of Johnson & Johnson (NYSE: JNJ) received the award in the “Wellness” category for its Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen). The drug-eluting contact, which provides a new wearing experience […]
Alcon SmartCataract study shows enhanced time savings during cataract surgery
Alcon (NYSE:ALC) announced data from a clinical study supporting the use of its SmartCataract solutions for cataract surgery. Geneva, Switzerland-based Alcon will present the data at this year’s American Society of Cataract and Refractive Surgery (ASCRS) meeting. According to a news release, Alcon’s latest data for the SmartCataract demonstrates significant time savings delivered during the […]
Alcon launches new dry eye treatment device
Alcon announced that it introduced the Systane iLux meibomian gland dysfunction (MGD) thermal pulsation system. Geneva, Switzerland-based Alcon designed the all-in-one, handheld Systane iLux MGD thermal pulsation device with new imaging technology to capture infrared photos and HD video of the meibomian glands. The system allows patients to see the need for treatment, visualize their […]
Staar Surgical implants first EVO Visian implantable Collamer lens
Staar Surgical today announced the first implants of the Evo Visian implantable Collamer lens in the U.S. Lake Forest, California-based Staar Surgical designed the Evo biocompatible implantable lens for the correction of myopia and myopia with astigmatism. The first implant was performed in a woman with myopia and astigmatism in her thirties who previously used […]
